Funding Opportunities

Our partners' latest funding opportunities are advertised below – the most recent opportunity is at the top of the list. Please scroll down for further opportunities and note that deadlines are included in the text of the post. Click on the links in the funding announcement section at the right to find general information about funding schemes offered by each of our partner organizations.

Latest Announcements
Topic Funding Announcements
Normal topic
American Society for Radiation Oncology call for grant and fellowship applications

The American Society for Radiation Oncology (ASTRO) is accepting applications from U.S. based early career scientists for the 2021 Grants and Fellowships Program. ASTRO is offering residents/fellows seed grants and career development awards to support novel research projects and foster the intellectual research talent currently entering the field of radiation oncology. ASTRO has also partnered with companies to offer ASTRO - Industry Radiation Oncology Research Training Fellowships that provide unique research training opportunities for U.S. based residents to work directly in the industry setting for up to one year. Please visit for more information. To apply and find the detailed Program Announcements please visit ProposalCentral.

Eligibility: U.S. based early career scientists

The fellowships deadline is January 8, 2021 and grants deadline is February 26, 2021

For questions please email

Normal topic
Cancer Grand Challenge: deadline 22 April 2021

Cancer Research UK and the US National Cancer Institute have united to define a new era in cancer research and discovery:

Cancer Grand Challenges: Dare to take on some of the most complex challenges in cancer   

Cancer Grand Challenges is a global funding platform founded by Cancer Research UK and the National Cancer Institute. Through a series of £20m ($25m) awards, Cancer Grand Challenges is giving international teams of researchers the freedom to think differently, act creatively and explore truly innovative science to take on complex questions in cancer. 

Nine new challenges to the international research community are now open for applications.
Call closes: 22 April 2021  

Cancer Grand Challenges news and updates – follow the team on Twitter and LinkedIn



Normal topic
World Cancer Research Fund International call for grant applications

World Cancer Research Fund International (WCRF International) is now accepting grant applications for research on the links between diet, nutrition (including body composition) and physical activity and cancer, as part of its Regular Grant Programme 2020/2021 cycle.

Please pass this information on to colleagues who might be interested in applying. Visit for more information.

Applications are accepted from principal investigators based at institutions in any country outside the Americas (North America, Central America and the Caribbean, and South America). Applications from the Americas can be submitted to the American Institute for Cancer Research at Applications from an eligible principal investigator with co-applicants/collaborators from anywhere in the world are welcome.

Only applications that meet the eligibility criteria and adhere to WCRF's research principles and themes will be considered. Please note the grant programme’s scope has been updated: applicants are encouraged to read the application guidelines carefully before applying
(link to guidelines PDF:

The deadline for applications is 16th November 2020.

Any questions can be emailed to, but please refer to the FAQs and guidelines document in the first instance.

Normal topic
Funding new arms of multi-arm trials for rare cancers

We, the Anticancer Fund, a Belgian non-profit organization with an international scope, have joined forces with the Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a Swiss-based non-profit organization, for a unique opportunity to support high quality clinical trials focusing on drug repurposing and therapy optimization, with special interest in the following areas:

  • Rare cancers (<6/100,000)
  • ‘Financial orphan’ drugs (commercially neglected drugs)
  • Off patent drugs
  • Prognostic and/or predictive biomarkers

We call upon all investigators to submit proposals, where funding is required to initiate a new arm of an existing multi-arm trial. Requirements include having a strong rationale with rigorous and compelling supportive data, in addition to a detailed statistical design and methodology.

Amount available for this call for proposals will be at least US$ 3 million. The amount allocated per grant will depend on the number of proposals selected for funding. Application Deadline is February 28, 2020

All information can be found here:

Please share this information with anyone potentially interested and/or retweet to spread the news:

Normal topic
Request for Applications - Trials in curative setting - International - Deadline 16 June 2019

We are seeking to support clinical trials aiming at reducing recurrence rates for cancer patients treated with curative intent.
The focus is on cancer types (or well-defined sub-types), with high rates of recurrence despite curative-intent treatments.

The funding can go to
- A new trial
- A new arm in an existing multi-arm trial
- Participation of an additional country in an existing international trial
- Extra-funding for an under-funded existing trial

You will find all details and eligibility criteria here:

Feel free to retweet the following tweet to inform your network about this opportunity:

Funding Announcements & Feeds


Links to general funding announcement for researchers pages for many of our member organizations are included below. Organizations are listed alphabetically. Where an organization has a specific focus that is not evident from the name, this is noted in brackets after the name. Organizations marked (CC) have a specific focus on childhood cancer. If you have any questions, please contact us.